NK 细胞仿生 MOF 纳米平台破坏缺氧适应实现肿瘤完全消融
NK cell biomimetic MOF nanoplatform disrupts hypoxia adaption for complete tumor ablation.
76.4分
★★★★☆
站内排序·非疗效
ALL SOURCES
NK cell biomimetic MOF nanoplatform disrupts hypoxia adaption for complete tumor ablation.
Advances and challenges in CAR-T cell therapy for breast cancer: from molecular design to clinical application.
Evaluation of Efficacy and Safety of Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cells in Breast Cancer: A Systematic Review and Meta-Analysis.
Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer.
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。